On the public citation graph

Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination

https://doi.org/10.1056/nejmc2110716
0 signed · 164 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1016/s0140-6736(20)31604-4openalex-snapshot
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
inferredcites →https://doi.org/10.1056/nejmoa2035389openalex-snapshot
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
inferredcites →https://doi.org/10.1056/nejmoa2102214openalex-snapshot
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
inferredcites →https://doi.org/10.1056/nejmoa2104840openalex-snapshot
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3890865openalex-extracted
inferred← citeshttps://doi.org/10.2139/ssrn.4000565openalex-extracted
Safety and Immunogenicity of Heterologous Boost Immunisation With an Aerosolized Ad5-nCoV After Two-Dose Priming With an Inactivated SARS-CoV-2 Vaccine CoronaVac in Adults: A Randomised, Open-Label, Parallel-Control Trial
inferred← citeshttps://doi.org/10.2139/ssrn.4001816openalex-extracted
inferred← citeshttps://doi.org/10.2139/ssrn.4066508openalex-extracted
Efficacy of Heterologous Boosting Using Recombinant SARS-CoV-2 Fusion Protein Vaccine: A Randomized, Double-Blind and Placebo-Controlled Phase III Trial
inferred← citeshttps://doi.org/10.1002/ajh.26418openalex-snapshot
Heterologous SARS‐CoV ‐2 vaccinations in patients with B‐cell lymphoid malignancies
inferred← citeshttps://doi.org/10.1002/art.42109openalex-snapshot
American College of Rheumatology Guidance for COVID ‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 4
inferred← citeshttps://doi.org/10.1002/art.42372openalex-snapshot
American College of Rheumatology Guidance for COVID ‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5
inferred← citeshttps://doi.org/10.1002/cti2.1379openalex-snapshot
Probabilistic classification of anti‐SARS‐CoV‐2 antibody responses improves seroprevalence estimates
inferred← citeshttps://doi.org/10.1002/cti2.70077openalex-snapshot
The impact of B‐cell reconstitution on mRNA vaccine responses in allogeneic stem cell transplant recipients
inferred← citeshttps://doi.org/10.1002/eji.202149645openalex-snapshot
Robust induction of neutralizing antibodies against the SARS‐CoV‐2 Delta variant after homologous Spikevax or heterologous Vaxzevria‐Spikevax vaccination
inferred← citeshttps://doi.org/10.1002/jvc2.174openalex-snapshot
Cutaneous leukocytoclastic vasculitis following COVID‐19 vaccination
inferred← citeshttps://doi.org/10.1007/s12519-021-00465-6openalex-snapshot
Expert consensus on COVID-19 vaccination in children
inferred← citeshttps://doi.org/10.1007/s40521-022-00311-8openalex-snapshot
Adverse Reactions to Anti-Infective Vaccines: an Emerging Problem in the COVID-19 Era
inferred← citeshttps://doi.org/10.1007/s40620-022-01446-2openalex-snapshot
Assessment of the humoral response to the homologous Gam-COVID-Vac (Sputnik V) or heterologous Sputnik V/mRNA-1273 (Moderna) vaccination against SARS-CoV-2 in dialysis patients
inferred← citeshttps://doi.org/10.1007/s42770-023-00935-1openalex-snapshot
IgA antibody dynamics in healthcare workers after CoronaVac® vaccination and heterologous Comirnaty® booster dose
inferred← citeshttps://doi.org/10.1016/j.addr.2026.115934openalex-snapshot
Redox-responsive LNPs for therapeutics delivery
inferred← citeshttps://doi.org/10.1016/j.biopha.2022.112650openalex-snapshot
Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine
inferred← citeshttps://doi.org/10.1016/j.cmi.2021.08.012openalex-snapshot
Which are the best coronavirus disease 2019 vaccines?
inferred← citeshttps://doi.org/10.1016/j.cmi.2022.05.009openalex-snapshot
Heterologous gam-COVID-vac (sputnik V)/mRNA-1273 (moderna) vaccination induces a stronger humoral response than homologous sputnik V in a real-world data analysis
inferred← citeshttps://doi.org/10.1016/j.ebiom.2021.103679openalex-snapshot
Safety and Cross-Variant Immunogenicity of a Three-Dose COVID-19 mRNA Vaccine Regimen in Kidney Transplant Recipients
inferred← citeshttps://doi.org/10.1016/j.ebiom.2022.104294openalex-snapshot
Dynamics of humoral and cellular immune responses after homologous and heterologous SARS-CoV-2 vaccination with ChAdOx1 nCoV-19 and BNT162b2
inferred← citeshttps://doi.org/10.1016/j.eclinm.2022.101529openalex-snapshot
Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study
inferred← citeshttps://doi.org/10.1016/j.ejca.2021.09.033openalex-snapshot
Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care
inferred← citeshttps://doi.org/10.1016/j.ejca.2021.10.014openalex-snapshot
Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.gaceta.2022.03.002openalex-snapshot
Hacia el control de la COVID-19 a través de la vacunación: obstáculos, desafíos y oportunidades. Informe SESPAS 2022
inferred← citeshttps://doi.org/10.1016/j.healun.2021.08.010openalex-snapshot
Third dose of the BNT162b2 vaccine in heart transplant recipients: Immunogenicity and clinical experience
inferred← citeshttps://doi.org/10.1016/j.isci.2021.103694openalex-snapshot
Increased neutralization of SARS-CoV-2 Delta variant after heterologous ChAdOx1 nCoV-19/BNT162b2 versus homologous BNT162b2 vaccination
inferred← citeshttps://doi.org/10.1016/j.isci.2023.106506openalex-snapshot
COVID-19 vaccine antibody responses in community-dwelling adults to 48 weeks post primary vaccine series
inferred← citeshttps://doi.org/10.1016/j.jcv.2022.105156openalex-snapshot
Immunogenicity and safety of homologous and heterologous ChAdOx1-S and mRNA-1273 vaccinations in healthy adults in Taiwan
inferred← citeshttps://doi.org/10.1016/j.jfma.2022.02.020openalex-snapshot
Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination
inferred← citeshttps://doi.org/10.1016/j.jfma.2022.07.010openalex-snapshot
Serological response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 prime-boost vaccination with a twelve-week interval
inferred← citeshttps://doi.org/10.1016/j.jfma.2022.09.004openalex-snapshot
Immunogenicity and safety of third-dose mRNA COVID-19 vaccines in healthy adults previously vaccinated with two doses of the ChAdOx1 vaccine
inferred← citeshttps://doi.org/10.1016/j.jfma.2023.04.017openalex-snapshot
Achievements of COVID-19 vaccination programs: Taiwanese perspective
inferred← citeshttps://doi.org/10.1016/j.jfma.2023.05.030openalex-snapshot
Immunogenicity and safety of heterologous mRNA-1273/MVC-COV1901 vaccination versus homologous mRNA1273 vaccination: A randomized, double-blind controlled study
inferred← citeshttps://doi.org/10.1016/j.jfma.2023.10.012openalex-snapshot
Immunogenicity and safety of heterologous booster with protein-based COVID-19 vaccine (NVX-CoV2373) in healthy adults: A comparative analysis with mRNA vaccines
inferred← citeshttps://doi.org/10.1016/j.jiph.2023.09.012openalex-snapshot
Significant increase in anti-SARS-CoV-2 antibodies after administration of heterologous mRNA-based vaccine booster in individuals receiving two doses of inactivated COVID-19 vaccine: A single-center study in healthcare workers in Jakarta, Indonesia
inferred← citeshttps://doi.org/10.1016/j.jvacx.2022.100242openalex-snapshot
Reactogenicity and immunogenicity of the intradermal administration of BNT162b2 mRNA vaccine in healthy adults who were primed with an inactivated SARS-CoV-2 vaccine
inferred← citeshttps://doi.org/10.1016/j.jval.2021.09.003openalex-snapshot
Immunogenicity and Safety of the COVID-19 Vaccines Compared With Control in Healthy Adults: A Qualitative and Systematic Review
inferred← citeshttps://doi.org/10.1016/j.jval.2021.12.011openalex-snapshot
Heterologous COVID-19 Vaccination in Spain: A Case Study of Individual Autonomy in the Real World
inferred← citeshttps://doi.org/10.1016/j.lanepe.2021.100249openalex-snapshot
Effectiveness of heterologous ChAdOx1 nCoV-19 and mRNA prime-boost vaccination against symptomatic Covid-19 infection in Sweden: A nationwide cohort study
inferred← citeshttps://doi.org/10.1016/j.lanepe.2023.100646openalex-snapshot
Vaccine-induced correlate of protection against fatal COVID-19 in older and frail adults during waves of neutralization-resistant variants of concern: an observational study
inferred← citeshttps://doi.org/10.1016/j.matcom.2025.09.010openalex-snapshot
Mathematical modeling of the effect of multiple vaccines on viral escape
inferred← citeshttps://doi.org/10.1016/j.medj.2022.05.003openalex-snapshot
Association of neutralizing breadth against SARS-CoV-2 with inoculation orders of heterologous prime-boost vaccines
inferred← citeshttps://doi.org/10.1016/j.vaccine.2022.03.060openalex-snapshot
Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates
inferred← citeshttps://doi.org/10.1016/j.vaccine.2022.07.023openalex-snapshot
Humoral immune response characterization of heterologous prime-boost vaccination with CoronaVac and BNT162b2
inferred← citeshttps://doi.org/10.1016/j.vaccine.2022.10.011openalex-snapshot
Evaluating Correlates of Protection for Mix-Match Vaccine Against COVID-19 VOCs With Potential of Evading Immunity
inferred← citeshttps://doi.org/10.1016/j.vaccine.2023.01.032openalex-snapshot
Safety and efficacy of COVID-19 prime-boost vaccinations: Homologous BBIBP-CorV versus heterologous BNT162b2 boosters in BBIBP-CorV-primed individuals
inferred← citeshttps://doi.org/10.1016/j.vaccine.2023.06.015openalex-snapshot
Protective immunity induced by an inhaled SARS-CoV-2 subunit vaccine
inferred← citeshttps://doi.org/10.1016/j.ymthe.2025.08.008openalex-snapshot
mRNA prime-boost vaccination promotes clonal continuity in germinal center reactions and broadens SARS-CoV-2 variant coverage
inferred← citeshttps://doi.org/10.1016/s0140-6736(21)01890-0openalex-snapshot
Department of Error
inferred← citeshttps://doi.org/10.1016/s0140-6736(21)01891-2openalex-snapshot
SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination
inferred← citeshttps://doi.org/10.1016/s0140-6736(21)02718-5openalex-snapshot
Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial
inferred← citeshttps://doi.org/10.1016/s0140-6736(21)02757-4openalex-snapshot
Mixing mRNA, adenoviral, and spike-adjuvant vaccines for protection against COVID-19
inferred← citeshttps://doi.org/10.1016/s0140-6736(22)00089-7openalex-snapshot
Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden
inferred← citeshttps://doi.org/10.1016/s1473-3099(22)00178-5openalex-snapshot
Emerging evidence on heterologous COVID-19 vaccine schedules—To mix or not to mix?
inferred← citeshttps://doi.org/10.1016/s2213-2600(21)00366-0openalex-snapshot
Heterologous ChAdOx1-nCoV19–BNT162b2 vaccination provides superior immunogenicity against COVID-19
inferred← citeshttps://doi.org/10.1016/s2213-2600(22)00087-xopenalex-snapshot
Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial
inferred← citeshttps://doi.org/10.1017/ash.2023.173openalex-snapshot
Longer-term effectiveness of a heterologous coronavirus disease 2019 (COVID-19) vaccine booster in healthcare workers in Brazil
inferred← citeshttps://doi.org/10.1017/dmp.2024.331openalex-snapshot
Effect of Inactivated Vaccines Against SARS-CoV-2 on Immunogenicity Outcome
inferred← citeshttps://doi.org/10.1038/s41423-021-00755-zopenalex-snapshot
Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination
inferred← citeshttps://doi.org/10.1038/s41423-023-01095-wopenalex-snapshot
B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity
inferred← citeshttps://doi.org/10.1038/s41467-021-27063-4openalex-snapshot
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
inferred← citeshttps://doi.org/10.1038/s41467-022-30162-5openalex-snapshot
Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants
inferred← citeshttps://doi.org/10.1038/s41467-022-32321-0openalex-snapshot
Comparative immunogenicity and reactogenicity of heterologous ChAdOx1-nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous COVID-19 vaccine regimens
inferred← citeshttps://doi.org/10.1038/s41467-022-33146-7openalex-snapshot
A randomized controlled trial of heterologous ChAdOx1 nCoV-19 and recombinant subunit vaccine MVC-COV1901 against COVID-19
inferred← citeshttps://doi.org/10.1038/s41467-023-35949-8openalex-snapshot
Structural basis for a conserved neutralization epitope on the receptor-binding domain of SARS-CoV-2
inferred← citeshttps://doi.org/10.1038/s41541-022-00452-6openalex-snapshot
Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy
inferred← citeshttps://doi.org/10.1038/s41541-023-00648-4openalex-snapshot
An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses
inferred← citeshttps://doi.org/10.1038/s41541-026-01483-zopenalex-snapshot
Long-term cross-variant Fc-mediated immune responses against SARS-CoV-2 induced by a heterologous adenoviral/inactivated virus prime-boost vaccination strategy
inferred← citeshttps://doi.org/10.1038/s41591-021-01677-zopenalex-snapshot
Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial
inferred← citeshttps://doi.org/10.1038/s41598-026-44645-8openalex-snapshot
Heterologous saRNA prime – multivalent protein boost strategy induces broad and durable immunity against SARS-CoV-2 and MERS-CoV
inferred← citeshttps://doi.org/10.1038/s43018-021-00274-wopenalex-snapshot
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study
inferred← citeshttps://doi.org/10.1038/s43018-021-00275-9openalex-snapshot
Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study
inferred← citeshttps://doi.org/10.1038/s44298-025-00144-7openalex-snapshot
Lactoferricin enables adenovirus infection of human skeletal muscle cells
inferred← citeshttps://doi.org/10.1056/nejmc2200415openalex-snapshot
Effectiveness of Homologous or Heterologous Covid-19 Boosters in Veterans
inferred← citeshttps://doi.org/10.1080/14760584.2021.1971522openalex-snapshot
To mix or not to mix? A rapid systematic review of heterologous prime–boost covid-19 vaccination
inferred← citeshttps://doi.org/10.1080/21645515.2021.2007015openalex-snapshot
Heterologous prime-boost vaccination against COVID-19: is it safe and reliable?
inferred← citeshttps://doi.org/10.1080/21645515.2022.2029111openalex-snapshot
Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort study
inferred← citeshttps://doi.org/10.1080/21645515.2023.2193074openalex-snapshot
Immunogenicity and safety of single booster dose of KD-414 inactivated COVID-19 vaccine in adults: An open-label, single-center, non-randomized, controlled study in Japan
inferred← citeshttps://doi.org/10.1080/21645515.2023.2209919openalex-snapshot
Safety of heterologous ChAdOx1-S/BNT162b2 primary schedule versus homologous BNT162b2 vaccination: Insights from an Italian post-marketing study, 2021
inferred← citeshttps://doi.org/10.1080/21645515.2023.2237387openalex-snapshot
Risk reduction analysis of mix-and-match vaccination strategy in healthcare workers during SARS-CoV-2 Omicron variant predominant period: A multi-center cohort study in Taiwan
inferred← citeshttps://doi.org/10.1080/22221751.2022.2088406openalex-snapshot
Efficacy of heterologous boosting against SARS-CoV-2 using a recombinant interferon-armed fusion protein vaccine (V-01): a randomized, double-blind and placebo-controlled phase III trial
inferred← citeshttps://doi.org/10.1084/jem.20220826openalex-snapshot
Humoral immunity to SARS-CoV-2 elicited by combination COVID-19 vaccination regimens
inferred← citeshttps://doi.org/10.1093/jtm/taab191openalex-snapshot
Heterologous prime–boost strategies for COVID-19 vaccines
inferred← citeshttps://doi.org/10.1093/ofid/ofac138openalex-snapshot
A Systematic Review of Coronavirus Disease 2019 Vaccine Efficacy and Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Disease
inferred← citeshttps://doi.org/10.1093/ofid/ofac449openalex-snapshot
Effectiveness of COVID-19 Vaccines Over Time Prior to Omicron Emergence in Ontario, Canada: Test-Negative Design Study
inferred← citeshttps://doi.org/10.1097/cm9.0000000000002567openalex-snapshot
Immunogenicity and reactogenicity of heterologous immunization schedules with COVID-19 vaccines: a systematic review and network meta-analysis
inferred← citeshttps://doi.org/10.1097/jsm.0000000000000981openalex-snapshot
COVID Vaccination in Athletes and Updated Interim Guidance on the Preparticipation Physical Examination During the SARS-Cov-2 Pandemic
inferred← citeshttps://doi.org/10.1097/tp.0000000000004260openalex-snapshot
Immunogenicity After a Heterologous BNT262b2 Versus Homologous Booster in Kidney Transplant Recipients Receiving 2 Doses of CoronaVac Vaccine: A Prospective Cohort Study
inferred← citeshttps://doi.org/10.1101/2021.07.09.21260251openalex-snapshot
The anti-SARS-CoV-2 immunoglobulin G levels and neutralising capacities against alpha and delta virus variants of concern achieved after initial immunisation with vector vaccine followed by mRNA vaccine boost are comparable to those after double immunisation with mRNA vaccines
inferred← citeshttps://doi.org/10.1101/2021.09.03.21263062openalex-snapshot
Heterologous prime-boost immunization with CoronaVac and Convidecia
inferred← citeshttps://doi.org/10.1101/2021.11.12.21266222openalex-snapshot
Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, January – September 2021
inferred← citeshttps://doi.org/10.1101/2022.03.29.22273086openalex-snapshot
Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July – November 2021
inferred← citeshttps://doi.org/10.1101/2022.05.13.22275049openalex-snapshot
Assessment of the humoral response to the homologous Gam-COVID-Vac (Sputnik V) or heterologous Sputnik V/mRNA-1273 (Moderna) vaccination against SARS-CoV-2 in dialysis patients
inferred← citeshttps://doi.org/10.1101/2023.02.16.23286009openalex-snapshot
Vaccine-induced correlate of protection against fatal COVID-19 in the old and frail during waves of neutralization resistant variants of concern
inferred← citeshttps://doi.org/10.1111/tid.13935openalex-snapshot
Humoral response to heterologous prime‐booster vaccination in heart transplant recipients aged 18–70 years primed with a viral vector SARS‐CoV‐2 vaccine
inferred← citeshttps://doi.org/10.1117/12.2691859openalex-snapshot
Protection of COVID-19 vaccine in general and special population
inferred← citeshttps://doi.org/10.1126/science.abn2688openalex-snapshot
Broad anti–SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 vaccination
inferred← citeshttps://doi.org/10.1128/spectrum.00609-22openalex-snapshot
Boosting with Multiple Doses of mRNA Vaccine after Priming with Two Doses of Protein Subunit Vaccine MVC-COV1901 Elicited Robust Humoral and Cellular Immune Responses against Emerging SARS-CoV-2 Variants
inferred← citeshttps://doi.org/10.1136/bcr-2022-249063openalex-snapshot
Case of reactive sacroiliitis possibly induced by an mRNA coronavirus disease vaccine
inferred← citeshttps://doi.org/10.1136/bmj-2022-070483openalex-snapshot
Safety of heterologous primary and booster schedules with ChAdOx1-S and BNT162b2 or mRNA-1273 vaccines: nationwide cohort study
inferred← citeshttps://doi.org/10.1159/000534540openalex-snapshot
COVID-19 in Patients with Chronic Lymphocytic Leukemia: What Have We Learned?
inferred← citeshttps://doi.org/10.1172/jci.insight.175401openalex-snapshot
Modulation of innate immune response to mRNA vaccination after SARS-CoV-2 infection or sequential vaccination in humans
inferred← citeshttps://doi.org/10.1177/08903344221103260openalex-snapshot
Human Milk Antibody Response After Combining Two Different COVID-19 Vaccines: Mix-and-Match
inferred← citeshttps://doi.org/10.1182/blood.2021014085openalex-snapshot
Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination
inferred← citeshttps://doi.org/10.1186/s12889-024-18598-4openalex-snapshot
Understanding the factors associated with COVID-19 vaccine hesitancy in Venezuela
inferred← citeshttps://doi.org/10.1186/s12916-021-02231-xopenalex-snapshot
Humoral immune response after different SARS-CoV-2 vaccination regimens
inferred← citeshttps://doi.org/10.1186/s12916-022-02480-4openalex-snapshot
Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July–November 2021
inferred← citeshttps://doi.org/10.1249/jsr.0000000000000912openalex-snapshot
COVID Vaccination in Athletes & Updated Interim Guidance on the Preparticipation Physical Examination during the SARS-CoV-2 Pandemic
inferred← citeshttps://doi.org/10.1371/journal.pgph.0003300openalex-snapshot
High prevalence of undocumented SARS-CoV-2 infections revealed by analysis of nucleocapsid-specific IgG responses in diagnosed and undiagnosed individuals
inferred← citeshttps://doi.org/10.1515/med-2024-0980openalex-snapshot
Immune response analysis of solid organ transplantation recipients inoculated with inactivated COVID-19 vaccine: A retrospective analysis
inferred← citeshttps://doi.org/10.1590/0074-02760230239openalex-snapshot
Assessment of immune responses to a Comirnaty® booster following CoronaVac® vaccination in healthcare workers
inferred← citeshttps://doi.org/10.17305/bjbms.2021.7082openalex-snapshot
Strategies and safety considerations of booster vaccination in COVID-19
inferred← citeshttps://doi.org/10.17802/2306-1278-2022-11-2-196-203openalex-snapshot
Booster vaccination against SARS-CoV-2: current challenges and solutions
inferred← citeshttps://doi.org/10.20473/ijtid.v11i2.39597openalex-snapshot
Different COVID-19 mRNA-based Vaccine Platforms as The Booster Dose and Their Impact on Omicron: A Literature-Based Overview
inferred← citeshttps://doi.org/10.21203/rs.3.rs-7875217/v1openalex-snapshot
Heterologous saRNA Prime – Multivalent Protein Boost Strategy Induces Broad and Durable Immunity Against SARS-CoV-2 and MERS-CoV
inferred← citeshttps://doi.org/10.2139/ssrn.4058228openalex-snapshot
Safety and Efficacy of Preventative COVID Vaccines: The StopCoV Study
inferred← citeshttps://doi.org/10.2215/cjn.0000000000000328openalex-snapshot
BNT162b2 versus mRNA-1273 Third Dose COVID-19 Vaccine in Patients with CKD and Maintenance Dialysis Patients
inferred← citeshttps://doi.org/10.3238/arztebl.m2022.0298openalex-snapshot
Self-reported reactogenicity after different COVID-19 vaccination regimens
inferred← citeshttps://doi.org/10.3346/jkms.2022.37.e180openalex-snapshot
Immunogenicity of COVID-19 Vaccination in Patients With End-Stage Renal Disease Undergoing Maintenance Hemodialysis: The Efficacy of a Mix-and-Match Strategy
inferred← citeshttps://doi.org/10.3349/ymj.2022.0298openalex-snapshot
Reactogenicity and Immunogenicity of the ChAdOx1 nCOV-19 Coronavirus Disease 2019 Vaccine in South Korean Healthcare Workers
inferred← citeshttps://doi.org/10.3389/fimmu.2021.821538openalex-snapshot
mRNA Vaccine: How to Meet the Challenge of SARS-CoV-2
inferred← citeshttps://doi.org/10.3389/fimmu.2022.961198openalex-snapshot
Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world
inferred← citeshttps://doi.org/10.3389/fimmu.2022.968105openalex-snapshot
Kinetics of vaccine-induced neutralizing antibody titers and estimated protective immunity against wild-type SARS-CoV-2 and the Delta variant: A prospective nationwide cohort study comparing three COVID-19 vaccination protocols in South Korea
inferred← citeshttps://doi.org/10.3389/fimmu.2023.1231274openalex-snapshot
Heterologous DNA-prime/protein-boost immunization with a monomeric SARS-CoV-2 spike antigen redundantizes the trimeric receptor-binding domain structure to induce neutralizing antibodies in old mice
inferred← citeshttps://doi.org/10.3389/fimmu.2025.1643083openalex-snapshot
Longitudinal evaluation of T-cell responses to Pfizer-BioNTech and Janssen SARS-CoV-2 vaccines as boosters in Ghanaian adults
inferred← citeshttps://doi.org/10.3389/fmed.2022.888631openalex-snapshot
Advances in COVID-19 Vaccines and New Coronavirus Variants
inferred← citeshttps://doi.org/10.3389/fmed.2022.994160openalex-snapshot
Comparison of vaccine-induced antibody neutralization against SARS-CoV-2 variants of concern following primary and booster doses of COVID-19 vaccines
inferred← citeshttps://doi.org/10.3389/fmed.2023.1147835openalex-snapshot
The immunologically high-risk kidney recipient in the early post-COVID-19 period. To do or not to do? A case report
inferred← citeshttps://doi.org/10.3390/biomedicines9091163openalex-snapshot
Anti-COVID-19 Vaccination in Patients with Autoimmune-Autoinflammatory Disorders and Primary/Secondary Immunodeficiencies: The Position of the Task Force on Behalf of the Italian Immunological Societies
inferred← citeshttps://doi.org/10.3390/jcm10173817openalex-snapshot
An Immunogenicity Report for the Comparison between Heterologous and Homologous Prime-Boost Schedules with ChAdOx1-S and BNT162b2 Vaccines
inferred← citeshttps://doi.org/10.3390/medicina57101010openalex-snapshot
Acute Transverse Myelitis after COVID-19 Vaccination
inferred← citeshttps://doi.org/10.3390/v14020380openalex-snapshot
Fighting Fire with Fire: Immunogenicity of Viral Vectored Vaccines against COVID-19
inferred← citeshttps://doi.org/10.3390/vaccines10020333openalex-snapshot
Homologous and Heterologous Anti-COVID-19 Vaccination Does Not Induce New-Onset Formation of Autoantibodies Typically Accompanying Lupus Erythematodes, Rheumatoid Arthritis, Celiac Disease and Antiphospholipid Syndrome
inferred← citeshttps://doi.org/10.3390/vaccines10030392openalex-snapshot
Effect of Heterologous Vaccination Regimen with Ad5-nCoV CanSinoBio and BNT162b2 Pfizer in SARS-CoV-2 IgG Antibodies Titers
inferred← citeshttps://doi.org/10.3390/vaccines10040491openalex-snapshot
Evaluation of Two-Month Antibody Levels after Heterologous ChAdOx1-S/BNT162b2 Vaccination Compared to Homologous ChAdOx1-S or BNT162b2 Vaccination
inferred← citeshttps://doi.org/10.3390/vaccines10050649openalex-snapshot
Differences in Immunogenicity of Three Different Homo- and Heterologous Vaccination Regimens against SARS-CoV-2
inferred← citeshttps://doi.org/10.3390/vaccines10050754openalex-snapshot
Frequency and Nuisance Level of Adverse Events in Individuals Receiving Homologous and Heterologous COVID-19 Booster Vaccine
inferred← citeshttps://doi.org/10.3390/vaccines10081241openalex-snapshot
Immune Response of a Heterologous mRNA-1273 Second-Dose Immunization after a First Dose of ChadOx1 against SARS-CoV-2: A Cross-Sectional Study
inferred← citeshttps://doi.org/10.3390/vaccines12040344openalex-snapshot
Immunogenicity and Safety of Half-Dose Heterologous mRNA-1273 Booster Vaccination for Adults Primed with the CoronaVac® and ChAdOx1-S Vaccines for SARS-CoV-2
inferred← citeshttps://doi.org/10.3390/vaccines12050515openalex-snapshot
Comparative Analysis of Vaccine-Induced Neutralizing Antibodies against the Alpha, Beta, Delta, and Omicron Variants of SARS-CoV-2
inferred← citeshttps://doi.org/10.3390/vaccines13050481openalex-snapshot
Challenges and Innovations in Pharmacovigilance and Signal Management During the COVID-19 Pandemic: An Industry Perspective
inferred← citeshttps://doi.org/10.3390/vaccines9101139openalex-snapshot
SARS-CoV-2 Neutralizing Antibody Levels Post COVID-19 Vaccination Based on ELISA Method—A Small Real-World Sample Exploration
inferred← citeshttps://doi.org/10.3390/vaccines9101163openalex-snapshot
The Effects of Heterologous Immunization with Prime-Boost COVID-19 Vaccination against SARS-CoV-2
inferred← citeshttps://doi.org/10.3904/kjm.2021.96.6.450openalex-snapshot
Heterologous Vaccination for Preparing COVID-19 Pandemic
inferred← citeshttps://doi.org/10.3947/ic.2022.0132openalex-snapshot
Humoral Immune Response of Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Prime-Boost Vaccination against SARS-CoV-2 Variants in Korea
inferred← citeshttps://doi.org/10.4103/ijmr.ijmr_474_21openalex-snapshot
Safety & effectiveness of COVID-19 vaccines
inferred← citeshttps://doi.org/10.4239/wjd.v14.i6.892openalex-snapshot
Correlation between COVID-19 vaccination and diabetes mellitus: A systematic review
inferred← citeshttps://doi.org/10.4274/eamr.galenos.2021.93695openalex-snapshot
COVID-19 Vaccines
inferred← citeshttps://doi.org/10.5339/qmj.2024.73openalex-snapshot
Short-term effects of COVID-19 vaccines on cardiac biomarkers: A comparative study between Pfizer/BioNTech and Sinopharm
inferred← citeshttps://doi.org/10.53738/revmed.2021.17.758.1910openalex-snapshot
Vaccins à ARN messager contre le Covid-19 : piqûre de rappel
inferred← citeshttps://doi.org/10.6084/m9.figshare.18849381openalex-snapshot
Additional file 1 of Humoral immune response after different SARS-CoV-2 vaccination regimens
inferred← citeshttps://doi.org/10.6084/m9.figshare.20786759openalex-snapshot
Additional file 1 of Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July–November 2021
inferred← citeshttps://doi.org/10.6084/m9.figshare.20786762openalex-snapshot
Additional file 2 of Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July–November 2021
inferred← citeshttps://doi.org/10.6084/m9.figshare.25678486openalex-snapshot
Additional file 1 of Understanding the factors associated with COVID-19 vaccine hesitancy in Venezuela
inferred← citeshttps://doi.org/10.6084/m9.figshare.25678692openalex-snapshot
Additional file 2 of Understanding the factors associated with COVID-19 vaccine hesitancy in Venezuela
inferred← citeshttps://doi.org/10.6084/m9.figshare.26710457openalex-snapshot
Additional file 3 of Understanding the factors associated with COVID-19 vaccine hesitancy in Venezuela
inferred← citeshttps://doi.org/10.6084/m9.figshare.26710460openalex-snapshot
Additional file 4 of Understanding the factors associated with COVID-19 vaccine hesitancy in Venezuela
inferred← citeshttps://doi.org/10.6084/m9.figshare.26710463openalex-snapshot
Additional file 5 of Understanding the factors associated with COVID-19 vaccine hesitancy in Venezuela
inferred← citeshttps://doi.org/10.7275/14754655openalex-snapshot
Influences impacting on parent involvement in an inner-city elementary school.
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.